Skip to main content
Clinical Trials/NCT04648878
NCT04648878
Completed
N/A

A Comparison of Conventional Physical Therapy, Powered Exoskeleton, and Hybrid Physical Therapy With Exoskeleton in the Treatment of Individuals With Sub-acute and Chronic Stroke.

Loma Linda University1 site in 1 country6 target enrollmentFebruary 14, 2021
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
Loma Linda University
Enrollment
6
Locations
1
Primary Endpoint
Timed up and go test
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this investigator-initiated study is to establish if powered exoskeleton therapy as a part of a rehabilitation program can be used as a standard of care in stroke rehabilitation.

Detailed Description

This prospective randomized control trial with three treatment arms will begin by: * Determining if the subject is a candidate for exoskeleton treatment. * Randomly assigning subjects to three groups (physical therapy only, exoskeleton only, or a hybrid of physical therapy and exoskeleton). * Body measurements to individualize the fit of the exoskeleton to each subject at each session. * Activities-based balance confidence (ABC) questionnaire will be administered before and after the study begins. * Timed up and go test (TUGT). * Ten-meter walk test (10MWT). * Six-minute walk test (6MWT) * Berg Balance Test (BBT). * Five times sit to stand (5XSTS). * Heart rate through a portable heartrate monitor.

Registry
clinicaltrials.gov
Start Date
February 14, 2021
End Date
December 18, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Males and Females 18 years of age or older post-stroke
  • 3 Ashworth score are involved in a standing program less than 220 lbs 5'0" through 6'4" have the ability to follow one-step commands near normal range-of-motion for the knees, hips, and ankles

Exclusion Criteria

  • Exclusion criteria will include those who have already experienced powered exoskeleton therapy.

Outcomes

Primary Outcomes

Timed up and go test

Time Frame: Pre and post tests up to six weeks apart

Subject sits in a standard armchair and stands, and at a self-selected walking speed, walks 3 meters, turns, and walks back to the chair, and sits down. They will be timed. Takes three minutes to administer.

Ten meter walk test

Time Frame: Pre and post tests up to six weeks apart

Subjects will be timed as they walk a known distance of 10 meters to determine his self-selected walking velocity (distance/time). They will be timed. Takes five minutes to administer.

6 minute walk test

Time Frame: Pre and post tests up to six weeks apart

This test measures distance walked in six minutes to assess a patient's physical endurance. They walk at a self-selected speed and will be timed. This test takes approximately 10 minutes to administer

Berg Balance Test

Time Frame: Pre and post tests up to six weeks apart

The Berg balance test is a reliable measure for predicting risk for fall. This 14-item test measures static and dynamic balance measures and takes 15-20 minutes to administer

The Activities-specific Balance Confidence (ABC) Scale

Time Frame: Pre and post tests up to six weeks apart

This has been shown to be an effective tool for assessing the psychological impact of balance impairment and falls and measuring an individual's balance confidence. Using a Likert scale, this self-administered test evaluates a person's confidence in balance over various activities. This 16-question test takes 5 to 10 minutes to complete.

Study Sites (1)

Loading locations...

Similar Trials